ABCA7 links sterol metabolism to the host defense system: Molecular background for potential management measure of Alzheimer's disease.
ABCA7 links sterol metabolism to the host defense system: Molecular background for potential management measure of Alzheimer's disease.
复制标题
ABCA7将类固醇代谢与宿主防御系统联系起来:阿尔茨海默病潜在管理措施的分子背景。
DOI:
10.1016/j.gene.2020.145316
复制
发表时间:
2021-02-05
期刊:
影响因子:
3.5
通讯作者:
Yokoyama S
中科院分区:
文献类型:
--
作者:
Abe-Dohmae S;Yokoyama S
ATP-binding cassette transporter (ABC) A7 is a membrane protein that belongs to the large family of ABC transporters. It is 54% homologous in amino acid residue sequence to ABCA1 which mediates biogenesis of plasma high density lipoprotein (HDL) from cellular phospholipid and cholesterol with extracellular helical apolipoproteins such as apolipoprotein (apo) A-I. When transfected and expressed, ABCA7 also mediates generation of HDL-like particles but small and of less cholesterol content. However, endogenous ABCA7 is unlikely involved in HDL biogenesis and rather to regulate the host-defense system such as phagocytotic function of the cells. ABCA1 expression is regulated by cellular cholesterol levels, positively by the liver X receptor (LXR) in extrahepatic peripheral cells. However, it is modulated dually in the liver being relevant to transport of cholesterol for its catabolism; positively by LXR and negatively by sterol regulatory element binding protein (SREBP) or hepatic nuclear factor 4α (HNF4α). In contrast, ABCA7 expression was shown to be regulated negatively by the SREBP system so that decrease of cell cholesterol enhances ABCA7 function such as cellular phagocytotic reaction, suggesting that it links cholesterol metabolism to the host defense system. The interest is being build up in ABCA7 as its genomic diversity has been found related to a risk for late-onset Alzheimer’s diseases. More recent findings indicate that ABCA7 is involved in metabolism of amyloid β peptide including its phagocytotic clearance. Accordingly, modulation of ABCA7 activity by manipulating cholesterol metabolism may open a new path for management of Alzheimer’s disease.
登录
查看更多内容
影响因子:
6.5
作者:
Abe-Dohmae, Sumiko;Kato, Koichi H.;Yokoyama, Shinji
通讯作者:
Yokoyama, Shinji
影响因子:
4.8
作者:
Arakawa, R;Yokoyama, S
通讯作者:
Yokoyama, S
影响因子:
4.8
作者:
Kim, WS;Fitzgerald, ML;Freeman, MW
通讯作者:
Freeman, MW
影响因子:
30.8
作者:
Bodzioch, M;Orsó, E;Schmitz, G
通讯作者:
Schmitz, G
DOI:
10.1006/bbrc.2000.3880
发表时间:
2000-11-30
影响因子:
3.1
作者:
Kaminski, WE;Piehler, A;Schmitz, G
通讯作者:
Schmitz, G